25Oct 2017

MYXOID LIPOSARCOMA WITH RARE ENTITY BREAST, THIGH AND PELVIS: CASE REPORT.

  • Medical intern , umm al Qura university, Makkah, Saudi Arabia.
  • Associate professor of pathology ; Department of pathology ,Faculty of medicine, Tanta university, Egypt.
  • Consultant Gyne-Oncology Department, King Abdullah Medical City, Makkah, Saudi Arabia.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Liposarcoma is a malignant tumor of mesenchymal origin, it is the second most frequent histological type of soft tissue sarcomas after fibrous malignant Histiocytoma. A 45-year- old female patient presented with huge intra-abdominal mass, extending into the upper pelvis and right thigh and involving all the posterior thigh muscle. CT scan of both regions "thigh and abdomen" showed a mass extending from diaphragm to the upper pelvis. Needle core biopsies from both masses, abdominal and thigh, showed neoplastic proliferation of small cells. Although Myxoid liposarcoma is a relatively rare malignancy, its diagnosis should be suspected in the presence of lesion of soft tissues and a histological and imaging investigation should be done without delay to confirm the diagnosis.

  1. Naik T, Kumar P, Kumar V. Primary Pleomorphic Liposarcoma of Liver: A Case Report and Review of the Literature. Case Reports Hepatol. 2013; 2013: 398910.
  2. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC Press; 2013.
  3. G?ransson M, Andersson MK, Forni C, St?hlberg A, Andersson C, Olofsson A, Mantovani R, AmanP.Themyxoidliposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.Oncogene. 2009 Jan 15;28(2):270-8
  4. Well differentiated myxoidliposarcoma. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/softtissueadiposemyxoidlipowd.html. Accessed October 11th, 2017.
  5. Conesa X, Seijas R, Ares o, Huguet p, Perez M. Multicentricliposarcoma. ActaOrthop Belg. 2011;77:9?14.
  6. Toombs BD, Kalisher L. Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol. 1977;129:673?676
  7. Yeh CN, Lin CH, Chen MF. Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies. Am Surg. 2004;70:287?290.
  8. Surov A, Fiedler E, Holzhausen HJ, Ruschke K, Schmoll HJ, Spielmann RP. Metastases to the breast from non-mammary malignancies: primary tumors, prevalence, clinical signs, and radiological features. AcadRadiol. 2011;18:565?574.
  9. Sauer T. Fine-needle aspiration cytology of extra mammary metastatic lesions in the breast: a retrospective study of 36 cases diagnosed during 18 years. Cytojournal. 2010;7:10.
  10. Yokouchi M, Nagano S, Kijima Y, Yoshioka T, Tanimoto A, Natsugoe S, Komiya S. Solitary breast metastasis from myxoidliposarcoma. BMC Cancer. 2014; 14: 482.
  11. Deeley TJ. Secondary deposits in the breast. Br J Cancer. 1965;19:738?743
  12. Reyna C, Lee MC. Breast cancer in young women: special considerations in multidisciplinary care. J MultidiscipHealthc. 2014; 7: 419?429
  13. Lee SK, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH. Characteristics of metastasis in the breast from extramammary malignancies. J SurgOncol. 2010;101:137?140
  14. Muttarak M, Nimmonrat A, Chaiwun B. Metastatic carcinoma to the male and female breast. AustralasRadiol. 1998;42:16?19.
  15. Goldblum JR, Weiss SW, Folpe AL. (Eds): Enzinger and Weiss?s Soft Tissue Tumors. 6. Philadelphia: Elsevier Inc; 2014.
  16. Estourgie S, Nielsen GP, Ott M. Metastatic patterns of extremity myxoidliposarcoma and their outcome.? J Surg Oncol.2002 80. 89-93. 10.1002/jso.10093
  17. Cheng EY, Springfield DS, Mankin HJ. Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma. Cancer. 1995;75:1120?1127
  18. Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999;85:85?92
  19. Saito T, Ryu M, Fukumura Y, Asahina M, Arakawa A, Nakai K et al. A case of myxoidliposarcoma of the breast. Int J ClinExpPathol. 2013; 6(7): 1432?1436
  20. Gharehdaghi M, Hassani M, Khooei AR, Ghodsi E, Taghizadeh A. Multicentricmyxoidliposarcoma; a case report and literature review. Arch Bone Jt Surg. 2014 Mar;2(1):79-81
  21. Loubignac F, Bourtoul C, Chapel F. Myxoidliposarcoma: a rare soft-tissue tumor with a misleading benign appearance. World J Surg Onco2009;7:42
  22. Sung MS, Kang HS, Suh JS, Lee JH, Park JM, Kim JY, Lee HG. Myxoidliposarcoma: appearance at MR imaging with histologic correlation. Radiographics. 2000 Jul-Aug;20(4):1007-19.
  23. Henze J, Bauer S. Liposarcomas. HematolOncolClin N Am 27 (2013) 939?55
  24. Noble JL, Moskovic E, Fisher C, Judson I. Imaging of Skeletal Metastases in MyxoidLiposarcoma. Sarcoma. 2010, Article ID 262361
  25. Prestwich RJ, Taylor RE, Grimer R: Metastatic myxoidliposarcoma: aggressive multimodality management. ClinOnc. 2005;17:130-4
  26. Lemeur M, Mattei JC, Souteyrand P, Chagnaud C, Curvale G, Rochwerger A. Prognostic factors for the recurrence of myxoidliposarcoma: 20 cases with up to 8 years follow-up. OrthopTraumatolSurg Res. 2015 Feb;101(1):103-7.
  27. Haniball J, Sumathi VP, Kindblom, LG et al., ?Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma,? Sarcoma, vol. 2011, Article ID 538085
  28. Nishida Y, Tsukushi S, Nakashima H, Ishiguro N. Clinicopathologic Prognostic Factors of Pure MyxoidLiposarcoma of the Extremities and Trunk Wall. Clin. Orthop. Relat. Res. 2010;468(11):3041-6
  29. Matthyssens LE, Creytens D, Ceelen WP. Retroperitoneal Liposarcoma: Current Insights in Diagnosis and Treatment. Front surg. 2015;2:4
  30. Costea R, Vasiliu E, Zarnescu NO, Hasouna M, Neagu S. Large thigh liposarcoma ? Diagnostic and therapeutic features. J Med Liife. 2011. Vol 4, No. 2
  31. Tseng WW, Somaiah N, Lazar AJ, Lev DC, Pollock RE. Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results. Cancers. 2013;5(2):529-549.
  32. Pitson G, Robinson P, Wilke D, Kandel RA, White L, Griffin AM, Bell RS, Catton CN, Wunder JS, O?Sullivan B. Radiation response: an additional unique signature of myxoidliposarcoma. Int J RadiatOncolBiol Phys. 2004;60:522?526
  33. Choi C, Park JH, Lee CG, Kim HJ, Suh CO, Cho J. Successful salvage treatment of myxoidliposarcomawith multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report. BMC Res Notes. 2015 May 2;8:179
  34. Katz D, Boonsirikamchai P, Choi H, et al. Efficacy of first-line doxorubicin and ifosfamide in myxoidliposarcoma. Clinical Sarcoma Research. 2012;2:2.

[Waad Ahmed AL Majnoni, Jumanah Ahmed AL Saedi, GhadaElsayed Esheba and Ahmed Ghazi. (2017); MYXOID LIPOSARCOMA WITH RARE ENTITY BREAST, THIGH AND PELVIS: CASE REPORT. Int. J. of Adv. Res. 5 (Oct). 1530-1535] (ISSN 2320-5407). www.journalijar.com

Waad Ahmed AL Majnoni
Medical intern , umm al

DOI:

Article DOI: 10.21474/IJAR01/5668      
DOI URL: https://dx.doi.org/10.21474/IJAR01/5668

Download Full Paper

Download PDF No. of Downloads: 11 | No. of Views: 68